Canadian intraoperative MRI technology developer IMRIS has raised $52.5 million in gross proceeds from its previously announced public offering of common shares.
In connection with the offering, IMRIS and a certain selling shareholder sold 11 million common shares at a public offering price of $5 per share, according to the Winnipeg, Manitoba-based firm.
Related Reading
Varian, IMRIS partner on MR-guided system, October 6, 2010
IMRIS gets Aussie OK for two systems, March 26, 2010
IMRIS to acquire NeuroArm Surgical, February 5, 2010
NeuroGrafix claims IMRIS patent infringement, December 21, 2009
IMRIS gets FDA nod, September 8, 2009
Copyright © 2010 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
